Cargando…

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

BACKGROUND: New predictors of the efficacy of hepatocellular carcinoma (HCC) immunotherapy are needed. The ability of a single gene mutation to predict the therapeutic effect of immune checkpoint inhibitors (ICI) in HCC remains unknown. METHODS: The most frequently mutated genes in HCC were analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yang, Tang, Rui, Li, Xiangzhao, Wang, Biao, Cheng, Yanling, Xiao, Shuzhe, Sun, Penghui, Yu, Wenxuan, Li, Cheng, Lin, Xinsheng, Zhu, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957351/ https://www.ncbi.nlm.nih.gov/pubmed/35345553 http://dx.doi.org/10.2147/JHC.S348785

Ejemplares similares

Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
por: Zhu, Yun, et al.
Publicado: (2021)

Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
por: Dong, Yawen, et al.
Publicado: (2021)

Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration
por: Guan, Rui, et al.
Publicado: (2021)

Should cancer patients receiving ICIs received COVID-19 vaccination?
Publicado: (2021)

The effect of pretreatment BMI on the prognosis and serum immune cells in advanced LSCC patients who received ICI therapy
por: Wang, Fei, et al.
Publicado: (2021)

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
por: Cheng, Chunxia, et al.
Publicado: (2020)

Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence
por: Yang, Jianming, et al.
Publicado: (2023)

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022)

The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker Development
por: Sacdalan, Danielle Benedict, et al.
Publicado: (2021)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

ICIS05 CONFERENCE
por: Lau, C, et al.
Publicado: (02/1)

The Icy Realm of the Rime
por: Potter, Polyxeni
Publicado: (2011)

Tumor PHD2 Expression Is Correlated With Clinical Features and Prognosis of Patients With HCC Receiving Liver Resection
por: Zhen, Li, et al.
Publicado: (2014)

Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
por: Zhang, Rui-kun, et al.
Publicado: (2021)

Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC
por: Liu, Zijing, et al.
Publicado: (2021)

Effect and Mechanism of LRP6 on Cardiac Myocyte Ferroptosis in Myocardial Infarction
por: Li, Rui-lin, et al.
Publicado: (2021)

Enceladus and the icy moons of Saturn
por: Schenk, Paul M, et al.
Publicado: (2018)

Ici, priorité ... aux piétons !
Publicado: (2002)

L'espion d'ici
por: Omnes, Roland
Publicado: (2000)

Synapse-specific Lrp4 mRNA enrichment requires Lrp4/MuSK signaling, muscle activity and Wnt non-canonical pathway
por: Jing, Hongyang, et al.
Publicado: (2021)

Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency
por: Xiang, Jing, et al.
Publicado: (2023)

The Association of HMGB1 Gene with the Prognosis of HCC
por: Xiao, Jianbiao, et al.
Publicado: (2014)

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
por: Zhai, Xiangyu, et al.
Publicado: (2022)

ICIS workshop on adnexal mass characterization
por: Rockall, Andrea
Publicado: (2014)

How to Detect Life on Icy Moons
por: Sephton, Mark A., et al.
Publicado: (2018)

Thermal picks for anchoring on icy moons
por: Halperin, Adam H., et al.
Publicado: (2019)

Intravesical ICIs to reduce toxicity in NMIBC
por: Masone, Maria Chiara
Publicado: (2022)

Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review
por: Baltussen, Joosje C., et al.
Publicado: (2021)

Construction of an immunogenic cell death-based risk score prognosis model in breast cancer
por: Li, Yanling, et al.
Publicado: (2022)

TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients
por: He, Guolin, et al.
Publicado: (2020)

A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer
por: Li, Jiazheng, et al.
Publicado: (2023)

Case report: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis
por: Pang, Ling, et al.
Publicado: (2022)

PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer
por: Ren, Zhixuan, et al.
Publicado: (2023)

The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database
por: Yang, Huaju, et al.
Publicado: (2023)

Lrp4 in astrocytes modulates glutamatergic transmission
por: Sun, Xiang-Dong, et al.
Publicado: (2016)

An Overview of Biomarkers and Molecular Signatures in HCC
por: Yim, Seon-Hee, et al.
Publicado: (2010)

Response in post-menopausal patients on ICI 118630.
por: Robertson, J. F., et al.
Publicado: (1987)

Integrated science in digital age: icis 2019
por: Antipova, Tatiana
Publicado: (2019)

Nouvelles d'ici et d'ailleurs /
Publicado: (1987)

An Icy Vista from a Golden Age
por: Breedlove, Byron
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2t755idcao1tre7i1j5d9f64pc